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Laboratory PCR for SARS-CoV-2 detection
Extraction of viral nucleic acid from respiratory specimens was performed using EZ1 virus mini kit v2.0 (Qiagen) according to manufacturer's instruction. The RNA was eluted in 60μl of AVE buffer and used as template for all assays. For both assays, a 20μl reaction containing 5μl RNA template, 500nm each of forward and reverse primer, 150nm probe and 0.2μl QuantiTect RT mix was prepared using QuantiTect Probe RT-PCR kit (Qiagen). All reactions were run on LightCycler 2.0 instrument (Roche).
All samples were also tested for endogenous RNAse P as an internal control.
Clinical features of subjects positive for SARS-CoV-2
Patient 1 reported onset of fever and cough on January 30, 2020 with only left lower zone atelectasis noted on admission chest radiograph. During her inpatient admission, she required increasing amounts of supplemental oxygen with progressive infiltrates on serial chest radiograph She was initiated on oral lopinavir-ritonavir (February 2, 2020) and electively intubated (February 6, 2020). Subsequently, her respiratory function improved with successful extubation on February 8, 2020. Repeat SARS-CoV-2 nasopharyngeal swabs were positive with the latest positive test being on February 9, 2020 ( Figure S1 ). Subsequent tests were negative and the patient was discharged well on February 16 th , 2020.
Patient 2 reported symptoms of fever and sore throat on January 30, 2020 with chest radiograph on admission revealing bilateral airspace opacification in the perihilar regions and right lower zone. She did not report close contact with a known COVID-19 case or any hospital visit in Wuhan. She required a maximum of 4L intranasal oxygen supplementation in the first five days of admission and was subsequently stable on room air. Her latest SARS-CoV-2 positive test was on February 7, 2020 with nasopharyngeal swabs on February 8 and February 9, 2020 testing negative. She was discharged well on February 10, 2020.
Patient 3, a 17-year-old male with no comorbidities, was the close contact of Patient 1, his mother. Upon direct questioning, he reported no symptoms in the two weeks prior to arriving in Singapore. Physical examination, laboratory tests and chest radiograph on admission did not reveal any abnormalities except for mild neutropenia. He did not require any supplemental oxygen and only reported mild symptoms including two episodes of diarrhea on 
Estimation of point prevalence among Singaporeans evacuated from Wuhan
The variables for estimation of point prevalence among Singaporeans evacuated from Wuhan (Table S1 ). For notational simplicity we define a redundant parameter = 1 − − to be the asymptomatic rate. As we fit the model using a Bayesian framework, prior distributions are required for these parameters. We assume non-informative uniform priors on (0,1) for and , and a non-informative Dirichlet(1,1,1) distribution for ( , , ). The (prospective) evacuees were partitioned into the states defined in Table S2 . These states correspond to the flows described in Figure 1 in the main manuscript. From the diagram of the disposition of subjects (Figure 1) , we tabulated the number of individuals ! in state and the probability ! of being in that state (Table S3 ). Note that we merge states and because they are functionally the same. The data vector 6 "# , $ , % , & , ' 7 should then follow a multinomial distribution with probabilities 6 "# , $ , % , & , ' 7 whence the likelihood function and hence the posterior distribution is obtained. 
A Markov chain Monte Carlo algorithm was developed to sample the posterior distribution for the parameter vector, using a random walk Metropolis-Hastings proposer with bandwidths tuned on pilot runs, 1,000,000 draws with every tenth draw retained and a burn in of 100,000 iterations. Convergence was assessed visually and through running multiple chains.
The algorithm was developed using R (R Core Team, 2020).
For our baseline scenario, we exclude the three individuals denied boarding, exclude one asymptomatic case who was the family member of an existing case and thus potentially infected through familial contact, and treat the one asymptomatic case in which a single gene target was detected as uninfected.
